FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2775308736> ?p ?o ?g. }

• W2775308736 endingPage "85" @default.
• W2775308736 startingPage "74" @default.
• W2775308736 abstract "Cancer treatments using stem cells expressing therapeutic genes have been identified for various types of cancers. In this study, we investigated inhibitory effects of HB1.F3.CD and HB1.F3.CD.IFN-β cells expressing Escherichia coli cytosine deaminase (CD) and human interferon-β (IFN-β) genes in intravenously (i.v.) injected mice with a metastasis model. In this treatment, pro-drug 5-fluorocytosine (5-FC) is converted to cytotoxic drug 5-fluorouracil by hNSCs expressing the CD gene, which inhibits DNA synthesis in cancer cells. Moreover, IFN-β induces apoptosis and reduces the growth of cancer cells. Upon MTT assay, proliferation of choriocarcinoma (JEG-3) cells decreased when co-cultured with hNSCs expressing CD and IFN-β genes. To confirm the cancer-tropic effect of these stem cells, chemoattractant factors (VEGF, CXCR4, and C-kit) secreted from JEG-3 cells were identified by polymerase chain reaction. hNSCs migrate toward JEG-3 cells due to ligand-receptor interactions of these factors. Accordingly, the migration capability of hNSCs toward JEG-3 cells was confirmed using an in vitro Trans-well assay, in vivo subcutaneously (s.c.) injected mice groups (xenograft model), and metastasis model. Intravenously injected hNSCs migrated freely to other organs when compared to s.c. injected hNSCs. Thus, we confirmed the inhibition of lung and ovarian metastasis of choriocarcinoma by i.v. injected HB1.F3.CD or HB1.F3.CD.IFN-β cells in the presence of 5-FC. Treatment of these stem cells also increased the survival rates of mice. In conclusion, this study showed that metastatic cancer was diminished by genetically engineered hNSCs and noncytotoxic drug 5-FC. This is the first report of the therapeutic potential of i.v. injected hNSCs in a metastasis model; therefore, the results indicate that this stem cell therapy can be used as an alternative novel tool to treat metastatic choriocarcinoma." @default.
• W2775308736 created "2017-12-22" @default.
• W2775308736 creator A5040109906 @default.
• W2775308736 creator A5057243590 @default.
• W2775308736 creator A5070989428 @default.
• W2775308736 creator A5085073708 @default.
• W2775308736 date "2018-02-01" @default.
• W2775308736 modified "2023-10-17" @default.
• W2775308736 title "Cancer-Specific Inhibitory Effects of Genetically Engineered Stem Cells Expressing Cytosine Deaminase and Interferon-β Against Choriocarcinoma in Xenografted Metastatic Mouse Models" @default.
• W2775308736 cites W1506750579 @default.
• W2775308736 cites W1553465761 @default.
• W2775308736 cites W1931980719 @default.
• W2775308736 cites W1998169920 @default.
• W2775308736 cites W2011091860 @default.
• W2775308736 cites W2012128849 @default.
• W2775308736 cites W2017593380 @default.
• W2775308736 cites W2021451273 @default.
• W2775308736 cites W2021884192 @default.
• W2775308736 cites W2025324052 @default.
• W2775308736 cites W2028063483 @default.
• W2775308736 cites W2040233810 @default.
• W2775308736 cites W2043047945 @default.
• W2775308736 cites W2048525391 @default.
• W2775308736 cites W2054958270 @default.
• W2775308736 cites W2070277723 @default.
• W2775308736 cites W2073482182 @default.
• W2775308736 cites W2077028849 @default.
• W2775308736 cites W2077839119 @default.
• W2775308736 cites W2079183268 @default.
• W2775308736 cites W2084232786 @default.
• W2775308736 cites W2099759165 @default.
• W2775308736 cites W2101873759 @default.
• W2775308736 cites W2106868922 @default.
• W2775308736 cites W2119063785 @default.
• W2775308736 cites W2121590586 @default.
• W2775308736 cites W2177850607 @default.
• W2775308736 cites W2336242874 @default.
• W2775308736 cites W2346999680 @default.
• W2775308736 cites W2410590795 @default.
• W2775308736 cites W2483396162 @default.
• W2775308736 cites W2494771026 @default.
• W2775308736 cites W2511241783 @default.
• W2775308736 cites W2577631485 @default.
• W2775308736 doi "https://doi.org/10.1016/j.tranon.2017.11.003" @default.
• W2775308736 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5723382" @default.
• W2775308736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29202279" @default.
• W2775308736 hasPublicationYear "2018" @default.
• W2775308736 type Work @default.
• W2775308736 sameAs 2775308736 @default.
• W2775308736 citedByCount "7" @default.
• W2775308736 countsByYear W27753087362018 @default.
• W2775308736 countsByYear W27753087362019 @default.
• W2775308736 countsByYear W27753087362021 @default.
• W2775308736 countsByYear W27753087362022 @default.
• W2775308736 countsByYear W27753087362023 @default.
• W2775308736 crossrefType "journal-article" @default.
• W2775308736 hasAuthorship W2775308736A5040109906 @default.
• W2775308736 hasAuthorship W2775308736A5057243590 @default.
• W2775308736 hasAuthorship W2775308736A5070989428 @default.
• W2775308736 hasAuthorship W2775308736A5085073708 @default.
• W2775308736 hasBestOaLocation W27753087361 @default.
• W2775308736 hasConcept C104317684 @default.
• W2775308736 hasConcept C109159458 @default.
• W2775308736 hasConcept C111599444 @default.
• W2775308736 hasConcept C121608353 @default.
• W2775308736 hasConcept C153911025 @default.
• W2775308736 hasConcept C154317977 @default.
• W2775308736 hasConcept C201750760 @default.
• W2775308736 hasConcept C202751555 @default.
• W2775308736 hasConcept C203014093 @default.
• W2775308736 hasConcept C2776178377 @default.
• W2775308736 hasConcept C2777748644 @default.
• W2775308736 hasConcept C2779013556 @default.
• W2775308736 hasConcept C2780832733 @default.
• W2775308736 hasConcept C28328180 @default.
• W2775308736 hasConcept C34981463 @default.
• W2775308736 hasConcept C502942594 @default.
• W2775308736 hasConcept C54355233 @default.
• W2775308736 hasConcept C55427017 @default.
• W2775308736 hasConcept C55493867 @default.
• W2775308736 hasConcept C86803240 @default.
• W2775308736 hasConcept C95444343 @default.
• W2775308736 hasConcept C96232424 @default.
• W2775308736 hasConceptScore W2775308736C104317684 @default.
• W2775308736 hasConceptScore W2775308736C109159458 @default.
• W2775308736 hasConceptScore W2775308736C111599444 @default.
• W2775308736 hasConceptScore W2775308736C121608353 @default.
• W2775308736 hasConceptScore W2775308736C153911025 @default.
• W2775308736 hasConceptScore W2775308736C154317977 @default.
• W2775308736 hasConceptScore W2775308736C201750760 @default.
• W2775308736 hasConceptScore W2775308736C202751555 @default.
• W2775308736 hasConceptScore W2775308736C203014093 @default.
• W2775308736 hasConceptScore W2775308736C2776178377 @default.
• W2775308736 hasConceptScore W2775308736C2777748644 @default.
• W2775308736 hasConceptScore W2775308736C2779013556 @default.
• W2775308736 hasConceptScore W2775308736C2780832733 @default.
• W2775308736 hasConceptScore W2775308736C28328180 @default.
• W2775308736 hasConceptScore W2775308736C34981463 @default.

• next